LDT Appeal: Looking at the Legal Nuances Behind Potential FDA Actions Following Court Decision
Marginal LDT scenarios could be where the FDA focuses on next, a lawyer notes
Enforcement-nir
Subscribe today for access to
Articles and Reports
LDT Oversight Remains Under CLIA, for Now
Judge rules that the FDA has ‘no authority’ to issue its rule governing laboratory-developed tests
Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
OIG Sets Enforcement Sights on Reform Efforts
...
Already a member? Log in here
Cybersecurity Gets Presidential Attention
...
Already a member? Log in here
FDA Holds LDT Workshop Amid Flurry of Debate as Comment Period Nears End
...
Already a member? Log in here
FTC Gets Ready to Flex Enforcement Muscle Regarding Healthcare Integration
...
Already a member? Log in here
Ohio State Lab Settles CLIA PT Referral Case
...
Already a member? Log in here
Labs Face Multiple Medicare Threats in New Legislative Year
...
Already a member? Log in here
CMS Proposes Changes to CLIA Proficiency Testing Rules
...
Already a member? Log in here